Russian Heart Failure Journal 2012year Chronic heart failure: epidemiology and planning aspects


To access this material please log in or register

Register Authorize
2012/№6

Chronic heart failure: epidemiology and planning aspects

Sitnikova M. Yu., Liasnikova E. А., Trukshina M. A.
Federal State Budgetary Institution, “North-West Federal Medical Research Center” of the RF Ministry of Health Care, Akkuratova 2, St.-Petersburg 197341

Keywords: prognosis, CHF, epidemiology

DOI: 10.18087 / rhfj.2012.6.1765

Chronic HF is a significant medical-social and economic problem of the modern society worldwide and in Russia, in particular. The epidemiological data of population studies of CHF of the 20th century confirm jump in its occurrence in recent decades and adverse prognosis. This review pays special attention to the National registers of HF patients, foundation for supervision of patients with severe CHF of the specialized outpatient and hospital centers oriented on hi-tech methods of treatment.
  1. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Committee for Practice Guidelines (CPG) / ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10 (10):933–989.
  2. Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics – 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.Circulation. 2007;115 (5):e69–171.
  3. McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33 (14):1787–1847.
  4. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93 (9):1137–1146.
  5. Zannad F, Agrinier N, Alla F. Heart failure burden and therapy. Europace. 2009;11 (Suppl 5):v1–9.
  6. Hoes AW, Mosterd A, Grobbee DE. An epidemic of heart failure? Recent evidence from Europe. Eur Heart J. 1998;19 (Suppl L): L2–9.
  7. Сулимов В. А, Напалков Д. А, Сеидова Н. М. Хроническая сердечная недостаточность: смещение фокуса на начальные стадии заболевания. Лечащий врач. 2008;4:58–60.
  8. Jonsson A, Ender M, Alehagen U et al. Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail. 2010;12 (1):25–31.
  9. Taylor СJ, Roalfe AK, Iles R et al. (Ten-year Prognosis of Heart Failure in the Community) Follow-up Data From the Echocardiographic Heart of England Screening (ECHOES) Study. Eur J Heart Fail. 2012;14 (2):176–184
  10. Roger VL. The Heart Failure Epidemic. Int J Environ Res Public Health. 2010;7 (4):1807–1830.
  11. Ho KK, Anderson KM, Kannel WB et al. Survival after the onset of congestive heart faliure in Framingham Heart Study subjects. Circulation. 1993;88 (1):107–115.
  12. Levy D, Kenchaiah S, Larson MG et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347 (18):1397–1402.
  13. Roger VL, Weston SA, Redfield MM et al. Trends in heart failure incidence and survival in a communitybased population. JAMA. 2004;292 (3):344–350.
  14. Mosterd A, Cost B, Hoes AW et al. The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J. 2001;22 (15):1318–1327.
  15. Cowie MR, Wood DA, Coats AJ et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J. 1999;20 (6):421–428.
  16. Cowie MR, Wood DA, Coats AJ et al. Survival of patients with a new diagnosis of heart failure: a population-based study. Heart. 2000;83 (5):505–510.
  17. Hobbs FD, Roalfe AK, Davis RC et al. Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J. 2007;28 (9):1128–1134.
  18. Teng TH, Hung J, Knuiman M et al. Trends in long-term cardiovascular mortality and morbidity in men and women with heart failure of ischemic versus non-ischemic aetiology in Western Australia between 1990 and 2005. Int J Cardiol. 2012;158 (3):405–410.
  19. Иванов С. Г, Краснова О. А, Ситникова М. Ю. и др. I / D полиморфизм гена АСЕ у больных с систолической сердечной недостаточностью: взаимосвязь с факторами риска и 5‑летней выживаемостью. Артериальная гипертензия. 2008;2 (2):115–119.
  20. Ситникова М. Ю., Лелявина Т. А., Шляхто Е. В. и др. Особен­ности клиники, диагностики и прогноза хронической сердечной недостаточности у госпитализированных пациентов старческого возраста. Журнал Сердечная Недостаточность. 2006;7 (2):85–87.
  21. Bahrami H, Kronmal R, Bluenke DA et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arh Intern Med. 2008;168 (19):2138–2145.
  22. Fonarow GC. Improving quality of care and outcomes for heart failure. Role of registries. Circ J. 2011;75 (8):1783–1790.
  23. Агеев Ф. Т., Арутюнов Г. П., Беленков Ю. Н. и др. Хроническая сердечная недостаточность. – М., «ГЭОТАР-Медиа», 2010. – 336с.
  24. Braunwald’s Heart Disease, 7th edition. – Elsevier Saunders. – 2005: 604.
  25. А service of U. S. National Institutes of Health. Avaliable at: http://clinicaltrials.gov
  26. Fabbri G, Gorini M, Maggioni AP et al. Italian Network on Congestive Heart Failure: ten-year experience. G Ital Cardiol. (Rome). 2006;7 (10): 689–694.
  27. Associazione Nazionale Medici Cardiologi Ospedalieri. Avaliable at: http://www.anmco.it / default.html
  28. Fonarow GC, Abraham WT, Albert NM et al. Influence of a Per­formance-Improvement Initiative on Quality of Care for Patients Hospitalized With Heart Failure: Results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med. 2007;167 (14):1493–1502.
  29. Fonarow GC, Albert NM, Curtis AB et al. Improving evidence-based care for heart failure in outpatient cardiology practices: Primary results of the Registry to Improve the Use of Evidence-based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010;122 (6):585–596.
  30. Fonarow GC, Albert NM, Curtis AB et al. Associations between outpatient heart failure process-of-care measures and mortality. Circulation. 2011;123 (15):1601–1610.
  31. Fonarow GC, Heywood JT, Heidenreich PA et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007;153 (6):1021–1028.
  32. Kociol RD, Hammill BG, Fonarow GC et al. Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries. Am Heart J. 2010;160 (5):885–892.
  33. Беленков Ю. Н., Васюк Ю. А., Галявич А. С. и др. Национальные Рекомендации ВНОК И ОССН по диагностике и лечению ХСН (третий пересмотр). Утверждены конференцией ОССН 15 декабря 2009 года. Журнал Сердечная недостаточность. 2010;11 (1):4–62.
  34. Беленков Ю. Н., Фомин И. В., Мареев В. Ю. и др. Первые результаты Российского эпидемиологического исследования по ХСН. Журнал Сердечная Недостаточность. 2003;4 (1):26–30.
  35. Беленков Ю. Н., Васюк Ю. А., Галявич А. С. и др. Национальные Рекомендации ВНОК И ОССН по диагностике и лечению ХСН (третий пересмотр). Утверждены конференцией ОССН 15 декабря 2009 года. Журнал Сердечная недостаточность. 2010;11 (1):4–62.
  36. Фомин И. В., Беленков Ю. Н., Мареев В. Ю. и др. Распростра­ненность хронической сердечной недостаточности в Евро­пей­ской части Российской Федерации – данные ЭПОХА–ХСН. Журнал Сердечная Недостаточность. 2006;7 (1):4–7.
  37. Беленков Ю. Н, Мареев В. Ю, Агеев Ф. Т. Эпидемиологические исследования сердечной недостаточности: состояние вопроса. Consilium Medicum. 2002;3:27–28.
  38. McDonagh TA, Blue L, Clark AL et al. European Society of Cardio­logy Heart Failure Association Standards for delivering heart failure care. Eur J Heart Fail. 2011;13 (3):235–241.
  39. Bello D, Shah NB, Edep ME et al. Self-reported differences between cardiologists and heart failure specialists in the management of chronic heart failure. Am Heart J. 1999;138 (1 Pt 1):100–107.
Sitnikova M. Yu., Liasnikova E. А., Trukshina M. A. Chronic heart failure: epidemiology and planning aspects. Russian Heart Failure Journal. 2012;13(6):372-376

To access this material please log in or register

Register Authorize
Ru En